Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-24-006763
Filing Date
2024-11-14
Accepted
2024-11-14 17:09:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8109491_13g-a.htm SC 13G/A 116101
  Complete submission text file 0000919574-24-006763.txt   117951
Mailing Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Filed by) CIK: 0001278386 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90737 | Film No.: 241464178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)